期刊文献+

胎盘间充质干细胞脐血血浆培养体系的建立 被引量:1

Establishment of cord blood plasma culture system for placenta-derived mesenchymal stem cell expansion
下载PDF
导出
摘要 目的建立并优化适用于临床级胎盘源间充质干细胞的脐血血浆体外培养体系。方法采用酶消化法分离胎盘间充质干细胞,分为胎牛血清组(10%胎牛血清+DMEM/F12)、脐血血浆组(10%脐血血浆+DMEM/F12+1 000 IU/L肝素)和无血清组(Stem ProMSC SFM CTSTM);经培养扩增后,采用流式细胞术检测间充质干细胞表面标志,并诱导细胞向成脂肪、成骨分化,比较3组培养扩增所得间充质干细胞的差异。结果 3组细胞的增殖速度并无明显差异;脐血血浆组、胎牛血清组及无血清组培养扩增所得的细胞均表达CD90、CD29、CD44、CD49e、CD105、CD73,不表达CD34、HLA-DR、CD45;而且均具有向成脂、成骨分化的能力。结论脐血血浆可取代胎牛血清或无血清培养基用于胎盘间充质干细胞的培养扩增,以此获取可供临床应用的胎盘间充质干细胞。 Objective To establish in vitro culture system of cord blood plasma optimized for clinically functional placenta- derived mesenchymal stem cells. Methods Collagenase digestion was applied for isolation of mesenchymal stem ceils (MSCs) from placenta. MSCs were divided into 3 separate groups based on different culture media, namely fetal bovine serum, cord blood plasma and serum - free medium. After cultured expansion, MSC surface markers were de- tected by flow cytometry. And MSCs were induced to differentiate into adipocyte or osteoblast. Differences of MSCs among the 3 groups were compared. Results There was no difference among the three groups in proliferation rate. CD90, CD29, CD44, CD49e, CD105 and CD73 were positive in all of the three groups while CD34, HLA - DR, CIM5 were negative. Cells in all of the three groups were able to differentiate into adipocyte and osteoblast. Conclusion Both fetal bovine ser- um and serum - free medium can be replaced by cord blood plasma in the in vitro cultured expansion of placenta - derived MSCs for clinical purposes.
出处 《广东医学》 CAS 北大核心 2015年第15期2312-2315,共4页 Guangdong Medical Journal
基金 国家自然科学基金资助项目(编号:81102248) 广东省科技计划项目(编号:2011B031800375) 广东省医学科研基金立项课题(编号:B2010274) 广州市医药卫生科技一般引导项目立项项目(编号:201102A213061) 广州市妇女儿童医疗中心博士科研启动基金项目(编号:201011)
关键词 间充质干细胞 脐血血浆 细胞培养 mesenchymal stem cell cord blood plasma cell cuhure
  • 相关文献

参考文献11

  • 1PAROLINI O, CARUSO M. Review: preclinical studies on pla- centa-derived cells and amniotic membrane: an update[J]. Pla- centa, 2011, 32 ( Suppl 2 ) : S186 - S195.
  • 2ILIC N, BROOKE G, MURRAY P, et al. Manufacture of clinical grade human placenta - derived muhipotent mesenchymal stromal cells[J]. Methods Mol Biol, 2011, 698:89 -106.
  • 3SPEES J L, GREGORY C A, SINGH I-I, et al. Internalized anti- gens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy[ J]. Mol Ther, 2004, 9(5) : 747 - 756.
  • 4MEULEMAN N, TONDREAU T, DELFORGE A, et al. Human marrow mesenchymal stem cell culture: serum free medium allows better expansion than classical alpha - MEM medium [J].Eur J Haematol, 2006, 76(4): 309-316.
  • 5MIZUNO N, SHIBA H, OZEKI Y, et al. Human autologous ser- um obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures[ J]. Cell Biol Int, 2006, 30(6) : 521 -524.
  • 6OPSILIN S L, WATHEN N C, TINGULSTAD S, et al. Tumor necrosis factor, interleukin -a, and interleukin -6 in normal hu- man pregnancy[J]. Am J Obstet Gynecol, 1993, 169(2 Pt 1 ) : 397 - 404.
  • 7MIZUNO N, SHIBA H, OZEKI Y, et al. Human autologous se- rum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures[ J]. Cell Biol Int, 2006, 30(6) : 521 -524.
  • 8SHETTY P, BHARUCHA K, TANAVDE V. Human umbilical ecord blood serum can replace fetal bovine serum in the culture of nlesenehymal stem cells[ J ]. Cell Biol lnl, 2007, 31 (3) : 293 - 298.
  • 9旷文勇,周新伏,李睿娟,郑敏翠.脐带血清和成人自体血清体外培养人骨髓间充质干细胞的比较[J].中国组织工程研究与临床康复,2009,13(45):8917-8921. 被引量:6
  • 10葛殿华,马红梅,周学武,呼晓,冯丽艳,雷娟,杨淑梅,毛慧玲,宁彬.脐带血血清培养体系扩增脐带间充质干细胞及其生物学特征的实验研究[J].黑龙江医药,2009,22(6):799-801. 被引量:3

二级参考文献30

  • 1孟丽娟,李建勇,陆化,吴汉新,吴冠宇,朱雨,刘澎,黄峻.间充质干细胞体外扩增联合自体外周血造血干细胞移植治疗恶性血液病[J].苏州大学学报(医学版),2005,25(2):252-255. 被引量:5
  • 2黄晓兵,刘霆,孟文彤,邓力,智伟,朱焕玲.骨髓间充质干细胞诱导成骨细胞模拟造血龛支持造血干/祖细胞增殖[J].中华血液学杂志,2006,27(12):795-800. 被引量:9
  • 3张媛,陈立梅,张雷,倪红霞.成人自体血清体外扩增培养骨髓间充质干细胞的生物学特性分析[J].中国组织工程研究与临床康复,2007,11(28):5523-5526. 被引量:2
  • 4Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The Internationa Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
  • 5Nuttall ME, Gimble JM. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol. 2004;4(3): 290-294.
  • 6Bonab MM, Alimoghaddam K, Talebian F, et al. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006;7:14.
  • 7Muguruma Y, Yahata T, Miyatake H, et al. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood. 2006;107(5):1878-1887.
  • 8Schilling T, Noth U, Klein-Hitpass L, et al. Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells. Mol Cell Endocrinol. 2007;271(1-2):1-17.
  • 9Delorme B, Chateauvieux S, Charbord P. The concept of mesenchymal stem cells. Regen Med. 2006;1(4):497-509.
  • 10Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate aUogeneic immune cell responses. Blood. 2005;105(4) 1815-1822.

共引文献7

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部